| human | Q5 |
| P496 | ORCID iD | 0000-0003-0307-055X |
| P69 | educated at | University of Cambridge | Q35794 |
| University of Western Australia | Q1517021 | ||
| P108 | employer | University of Cambridge | Q35794 |
| P106 | occupation | researcher | Q1650915 |
| Q67885828 | A clonal analysis of lung T cells derived by bronchoalveolar lavage of healthy individuals |
| Q70567972 | An analysis of the relationship between gamma delta T cell receptor V gene usage and non-major histocompatibility complex-restricted cytotoxicity |
| Q28295304 | CD161 (human NKR-P1A) signaling in NK cells involves the activation of acid sphingomyelinase |
| Q44946113 | Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE. |
| Q24658131 | Common genetic variation in candidate genes and susceptibility to subtypes of breast cancer |
| Q86554647 | Evaluating the performance of the breast cancer genetic risk models BOADICEA, IBIS, BRCAPRO and Claus for predicting BRCA1/2 mutation carrier probabilities: a study based on 7352 families from the German Hereditary Breast and Ovarian Cancer Consorti |
| Q33614244 | Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers |
| Q33892928 | Familial relative risks for breast cancer by pathological subtype: a population-based cohort study |
| Q73586066 | Human thymus contains 2 distinct dendritic cell populations |
| Q99210133 | Identification of Women at High Risk of Breast Cancer Who Need Supplemental Screening |
| Q47190168 | Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium |
| Q112572520 | Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes |
| Q35737888 | Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) |
| Q62583133 | Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes |
| Q37131918 | Polygenic risk score is associated with increased disease risk in 52 Finnish breast cancer families |
| Q97524107 | Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants |
| Q53150926 | Post-sanctions era in Iran: opportunity for science and publication. |
| Q36583004 | Prediction of breast cancer risk based on profiling with common genetic variants |
| Q46821200 | Reaction between ellagic acid and an ultimate carcinogen. |
| Q92708085 | Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers |
| Q40876924 | Signaling lymphocytic activation molecule (CDw150) is homophilic but self-associates with very low affinity. |
| Q58757999 | Switching from a restricted to an effective CD4 T cell response by activating CD8+ murine dendritic cells with a Toll-like receptor 9 ligand |
| Q27641965 | The ligand-binding face of the semaphorins revealed by the high-resolution crystal structure of SEMA4D |
| Q41494721 | The nature of major histocompatibility complex recognition by gamma delta T cells. |
Search more.